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Purpose: Febrile seizures (FS) are the most common convulsive event in children. Inﬂammatory elements
and genetics seem to have major roles in their pathogenesis.
Methods: Seventy nine patients with FS were enrolled in this study and compared with 140 controls.
Cytokine genotyping was performed, using polymerase chain reaction with sequence-speciﬁc primers.
The allele and genotype frequency of three single nucleotide polymorphisms (SNPs) within the IL-10
gene at -1082, -819 and -592 positions (rs1800896, rs1800871, rs1800872), and two SNPs within the
TGFB at codons 10 and 25 (rs1982037, rs1800471) were determined.
Results: No signiﬁcant difference was detected in allelic frequency of IL-10 at -1082, -819 and -592
positions (rs1800896, rs1800871, rs1800872) and TGFB at codon 25 (rs1800471), between patients and
controls. A signiﬁcant negative association was observed at the codon 10/CT (rs1982037) in the patient
group (OR, 0.5; 95%CI, 0.27–0.93; p = 0.026). Further, a negative association was detected in patients
with simple FS at same position (OR, 0.41; 95%CI, 0.18–0.93; p = 0.03), thus revealing a protective effects
in FS patients. There was no signiﬁcant difference in allelic and genotype frequency between simple and
complex FS samples. Furthermore, haplotype analysis revealed signiﬁcant difference in frequency of
TGFB/TC haplotype in comparison between complex FS patients and controls (p = 0.048).
Conclusion: Certain alleles, genotypes, and haplotypes in TGFB genes were over represented in patients
with FS, which possibly could predispose individuals to this disease.
 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights reserved.
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Seizure
jou r nal h o mep age: w ww.els evier . co m/lo c ate /ys eiz1. Introduction
Febrile seizure (FS) is the most common seizure in children with
a prevalence of 2.5% [1]. The International League Against Epilepsy
(ILAE) has deﬁned FS as ‘‘elevated or rapidly rising fever of short
duration associated with an uncomplicated seizure that does not
predispose to epilepsy and is not accompanied by neurologic
abnormalities, previous neonatal seizures or a previous unpro-
voked seizure, and not meeting criteria for other acute symptom-
atic seizures in children between 6months and 5 years of age’’* Corresponding author at: Children’s Medical Center Hospital, Dr Qarib St,
Keshavarz Blvd, Tehran 14194, Iran. Tel.: +98 21 6692 9234; fax: +98 21 6692 9235.
E-mail address: rezaei_nima@tums.ac.ir (N. Rezaei).
http://dx.doi.org/10.1016/j.seizure.2015.05.001
1059-1311/ 2015 British Epilepsy Association. Published by Elsevier Ltd. All rights re[2]. Simple FSs are generalized tonic-colonic seizures lasting less
than 15 min, only once in 24 h followed by a brief postictal period,
whereas complex FS, lasting more than 15 min has focal features and
multiple recurrences within 24 h and association with postictal
neurological abnormalities, for example Todd paresis [3,4].
Many studies demonstrated that there is relevance between
familial factors and occurrence of FSs; twin studies showed a
higher occurrence rate in monozygotic with FS than dizygotic ones
[5,1,6]. Several studies showed interaction between immune
inﬂammatory system, cytokines and genetic factors, which are
involved in FS [7–12].
IL-10 is a cytokine with multiple roles in inﬂammatory system.
It is known to relay negative feedback signals that diminish the
activated immune system after an inﬂammatory trigger [13].
Strausberg et al. reported that secretion of IL-10 was higher in theserved.
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that IL-10 production was increased in FS [15]. In a study of
neonatal seizures, Youn et al. demonstrated that IL-10 was
signiﬁcantly elevated in plasma 48–72 h after seizure onset. They
concluded the IL-10 levels surge 24–72 h after seizure onset may
indicate the enhanced protective role of it as an anticonvulsant by
suppressing proinﬂammatory cytokine production [16].
Transforming growth factor beta (TGFB) controls proliferation,
cellular differentiation and many other functions in cells. Animal
experiments showed TGFB up regulation as part of the inﬂammatory
response in the brains of amygdala-kindled rats and the hippocam-
pus of rats exposed to status epilepticus. These results indicate
potential involvement of TGFB in epileptogenesis [17,18].
We studied IL-10 and TGFB SNPs in a number of diseases
[19–26], but not FS. Meanwhile we have recently reportedTable 1
Comparison of allele and genotype frequency of IL-10 (-1082, -819, -592) polymorphis
Gene polymorphism Alleles/genotypes Patients
N = 79(%)
FS(simple and complex) and control
-1082(rs1800896) A 98 (63.6) 
G 56 (36.4) 
AA 27 (36) 
GA 42 (56) 
GG 6 (8) 
-819(rs1800871) C 113 (72.9) 
T 42 (27.1) 
CC 44 (57.9) 
CT 23 (30.3) 
TT 9 (11.8) 
-592(rs1800872) A 47 (31.8) 
C 101 (68.2) 
AA 9 (12.2) 
CA 29 (39.2) 
CC 36 (48.6) 
Simple FS and control
-1082(rs1800896) A 46 (59) 
G 32 (41) 
AA 12 (32.4) 
GA 20 (54.1) 
GG 5 (13.5) 
-819(rs1800871) C 59 (74.7) 
T 20 (25.3) 
CC 24 (63.1) 
CT 9 (23.7) 
TT 5 (13.1) 
-592(rs1800872) A 59 (74.7) 
C 20 (25.3) 
AA 24 (63.1) 
CA 9 (23.7) 
CC 5 (13.1) 
Complex FS and controls
-1082(rs1800896) A 52 (68.4) 
G 24 (31.6) 
AA 15 (39.5) 
GA 22 (57.9) 
GG 1 (2.6) 
-819(rs1800871) C 54 (71.1) 
T 22 (28.9) 
CC 20 (52.6) 
CT 14 (36.8) 
TT 4 (10.5) 
-592(rs1800872) A 27 (36.5) 
C 47 (63.5) 
AA 5 (13.5) 
CA 17 (45.9) 
CC 15 (40.5) 
*N, number of people in each group.association of IL-4 and IL-6 SNPs with FS [8,27]. This study was
conducted to ﬁnd out the associations of allelic frequency of IL-10
at -1082, -819 and -592 positions (rs1800896, rs1800871,
rs1800872) and TGFB at codons 10 and 25 (rs1982037,
rs1800471) with FS in a group of Iranian patients.
2. Patients and methods
2.1. Participants
In this study, children with FS (simple and complex FS) who
were referred to the Children’s Medical Center Hospital, the
Pediatrics Center of Excellence in Tehran, Iran, were enrolled.
Informed consent was obtained from the parents of each individual
before blood sampling, and the study was approved by the Ethicsms between FS patients and controls.
Controls
N = 140 (%)
Odds ratio (95% CI) p-value
181 (64.6) 0.96 (0.62–1.47) 0.96
99 (35.4) 1.04 (0.68–1.61) 1.04
53 (37.8) 0.92 (0.49–1.72) 0.92
75 (53.6) 1.1 (0.6–2.02) 1.1
12 (8.6) 0.93 (0.29–2.81) 0.93
199 (71.1) 1.1 (0.69–1.74) 1.1
81 (28.9) 0.91 (0.58–1.45) 0.91
71 (50.7) 1.34 (0.73–2.44) 1.34
57 (40.7) 0.63 (0.33–1.19) 0.63
12 (8.6) 1.43 (0.52–3.88) 1.43
81 (28.9) 1.14 (0.73–1.8) 0.61
199 (71.1) 0.87 (0.56–1.38) 0.61
12 (8.6) 1.45 (0.54–4) 0.55
57 (40.7) 0.94 (0.51–1.74) 0.94
71 (50.7) 0.92 (0.5–1.68) 0.88
181 (64.6) 0.79 (0.46–1.36) 0.43
99 (35.4) 1.27 (0.74–2.19) 0.43
53 (37.8) 0.79 (0.34–1.81) 0.67
75 (53.6) 1.02 (0.46–2.24) 0.89
12 (8.6) 2.42 (0.67–8.45) 0.15
199 (71.1) 1.2 (0.66–2.2) 0.62
81 (28.9) 0.83 (0.45–1.52) 0.62
71 (50.7) 1.67 (0.75–3.72) 0.23
57 (40.7) 0.45 (0.18–1.09) 0.08
12 (8.6) 1.62(0.46–5.43) 0.36
199 (71.1) 1.2 (0.66–2.2) 0.62
81 (28.9) 0.83 (0.45–1.52) 0.62
71 (50.7) 1.67 (0.75–3.72) 0.23
57 (40.7) 0.45 (0.18–1.09) 0.08
12 (8.6) 1.62 (0.46–5.43) 0.36
181 (64.6) 1.19 (0.67–2.11) 0.63
99 (35.4) 1.84 (0.47–1.5) 0.63
53 (37.8) 1.07 (0.48–2.37) 0.99
75 (53.6) 1.19 (0.54–2.62) 0.77
12 (8.6) 0.29 (0.01–2.26) 0.3
199 (71.1) 1 (0.55–1.82) 0.89
81 (28.9) 1 (0.55–1.81) 0.89
71 (50.7) 1.08 (0.5–2.35) 0.98
57 (40.7) 0.85 (0.38–1.89) 0.8
12 (8.6) 1.25 (0.32–4.57) 0.75
81 (28.9) 1.41 (0.79–2.5) 0.26
199 (71.1) 0.71 (0.4–1.26) 0.26
12 (8.6) 1.67 (0.47–5.61) 0.35
57 (40.7) 1.24 (0.56–2.73) 0.7
71 (50.7) 0.66 (0.3–1.47) 0.36
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involved 79 children with FS, aged 6 months to 6 years, [8,27] and
140 control subjects without a history of FS [28]. Diagnosis of FSs
followed the criteria established in the 1989 International
Classiﬁcation of Epileptic Syndromes. The age at ﬁrst FS was
between 6 month and 6 years of age. The EEG was normal for all
patients or showed mild nonspeciﬁc abnormalities. Patients with
FS beginning at the age of 6 years or later, epileptiform EEG traits or
evidence of intracranial infection were not included in this study.
The studied population was in Hardy–Weinberg equilibrium for IL-
10 and TGFB SNPs (Chi square = 1.98, p-value = 0.3716 and Chi
square = 0.13, p-value = 0.9371, respectively).
2.2. Genotyping
DNA was extracted from peripheral blood. Cytokine genotyping
was performed, using polymerase chain reaction with sequence-
speciﬁc primers (PCR-SSP assay kit, Heidelberg University), as
explained before [28]. Brieﬂy, the gene was ampliﬁed, using a
Tedane Flexigene thermal cycler. The availability of the PCR
products was assessed, using 2% agarose gel electrophoresis. The
gel was placed on a UV transilluminator, and a digital image was
taken for analysis and documentation. The frequencies of alleles,
genotypes, and haplotypes of IL-10 (at positions -1082, -819 and -
592) and TGFB (at codons 10 and 25) were recorded. When an
allele was not detected, the case was excluded from this study.
Thus, 82 and 59 patients were enrolled for IL-10 and TGFB SNPs
study, respectively.Table 2
Comparison of TGF-b (codons 10 and 25) polymorphisms between FS patients and con
Position Alleles/genotypes Patients
N = 79 (%)
FS (simple and complex) and control
Codon 10(rs1982037) C 76 (48.1) 
T 82 (51.9) 
CC 19 (25.3) 
CT 37 (49.3) 
TT 19 (25.3) 
Codon 25(rs1800471) C 11 (7.2) 
G 142 (92.8) 
CC 3 (3.9) 
CG 5 (6.6) 
GG 68 (89.5) 
Simple FS and control
Codon 10(rs1982037) C 33 (42.3) 
T 45 (57.7) 
CC 8 (22.2) 
CT 16 (44.4) 
TT 12 (33.3) 
Codon 25(rs1800471) C 4 (5.5) 
G 69 (94.5) 
CC 1 (2.8) 
CG 2 (5.5) 
GG 33 (91.7) 
Complex FS and control
Codon 10(rs1982037) C 43 (53.8) 
T 37 (46.2) 
CC 11 (28.2) 
CT 21 (53.8) 
TT 7 (17.9) 
Codon 25(rs1800471) C 7 (8.75) 
G 73 (91.25) 
CC 2 (5) 
CG 3 (7.5) 
GG 35 (87.5) 
*N, number of people in each group.
Bold value indicates the p value is below 0.05 and the genotype and haplotype differe2.3. Statistical analysis
We estimated allele frequencies by direct gene counting and
compared them using the chi-square test. The odds ratio (OR) and
Wald’s 95% conﬁdence interval (CI) were calculated for each allele,
genotype, and haplotype. A p-value <0.05 considered to be
statistically signiﬁcant. The frequency of each genotype/haplo-
type is compared to frequency of the sum of other genotypes/
haplotypes.
3. Results
3.1. Allele and genotype polymorphisms
Tables 1 and 2 present the allele frequency (number and
percentage), p-value, and OR with its 95% CI in FS patients
and controls. We found no signiﬁcant differences in the allele
frequency of IL-10 at -1082, -819 and -592 positions (rs1800896,
rs1800871, rs1800872) and TGFB at codon 25 (rs1800471),
between patients and controls. A signiﬁcant negative association
was observed at the codon 10/CT (rs1982037) in the patient
group (OR, 0.5; 95%CI, 0.27–0.93; p = 0.026). Further, a negative
association was detected in patients with simple FS at the same
position (OR, 0.41; 95%CI, 0.18–0.93; p = 0.03), thus revealing a
protective effects in FS patients. There were no signiﬁcant
differences in allele and genotype frequency between simple
and complex FS samples.trols.
Controls N = 140 (%) OR (95%CI) p-value
131 (47.5) 1.03 (0.68–1.55) 0.97
145 (52.5) 0.97 (0.65–1.47) 0.97
20 (14.5) 2 (0.94–4.29) 0.7
91 (65.9) 0.5 (0.27–0.93) 0.026
27 (19.6) 1.39 (0.68–2.87) 0.42
21 (7.6) 0.94 (0.41–2.12) 0.97
255 (92.4) 1.06 (0.47–2.43) 0.97
2 (1.5) 2.79 (0.37–24.51) 0.35
17 (12.3) 0.5 (0.15–1.53) 0.27
119 (86.2) 1.36 (0.53–3.59) 0.64
131 (47.5) 0.81 (0.47–1.39) 0.49
145 (52.5) 1.23 (0.72–2.11) 0.49
20 (14.5) 1.69 (0.61–4.58) 0.38
91 (65.9) 0.41 (0.18–0.93) 0.03
27 (19.6) 2.06 (0.85–4.97) 0.12
21 (7.6) 0.7 (0.2–2.27) 0.7
255 (92.4) 1.42 (0.44–5.07) 0.7
2 (1.5) 1.94 (0–28.5) 0.5
17 (12.3) 0.42 (0.06–2.03) 0.37
119 (86.2) 1.76 (0.45–7.97) 0.57
131 (47.5) 1.29 (0.76–2.18) 0.38
145 (52.5) 0.78 (0.46–1.32) 0.38
20 (14.5) 2.32 (0.92–5.81) 0.08
91 (65.9) 0.6 (0.28–1.32) 0.23
27 (19.6) 0.9 (0.32–2.43) 0.99
21 (7.6) 1.16 (0.43–3.04) 0.92
255 (92.4) 0.86 (0.33–2.32) 0.92
2 (1.5) 3.58 (0.35–37.08) 0.22
17 (12.3) 0.58 (0.13–2.26) 0.57
119 (86.2) 1.12 (0.36–3.7) 0.95
nce between cases and controls are signiﬁcant.
Table 3
Comparison of IL-10 (-1082, -819, -592/rs1800896, rs1800871, rs1800872) and TGF-b (codons 10 and 25/rs1982037, rs1800471) haplotypes between FS patients and
controls.
Cytokine Haplotype Patients
N = 79 (%)
Controls
N = 140 (%)
OR (95%CI) p-value
FS (simple and complex) and control
IL-10 GCC 50 (38.2) 99 (35.4) 1.13(0.72–1.77) 0.6
ACC 46 (35.1) 100 (35.7) 0.97(0.62–1.54) 1
ATA 35 (26.7) 81 (28.9) 0.9(0.55–1.46) 0.7
TGF-b CG 67 (44.4) 110 (39.9) 1.2(0.79–1.83) 0.4
TG 74 (49) 145 (52.5) 0.87(0.57–1.32) 0.55
CC 8 (5.3) 21 (7.6) 0.68(0.27–1.67) 0.5
TC 2 (1.3) 0 (0) 0.1
Simple FS and control
IL-10 GCC 29 (43.3) 99 (35.4) 1.4(0.78–2.48)
ACC 22 (32.8) 100 (35.7) 0.88(0.48–1.6) 0.3
ATA 16 (23.9) 81 (28.9) 0.77(0.4–1.49) 0.8
0.5
TGF-b CG 29 (39.7) 110 (39.9) 0.99(0.57–1.74) 0.9
TG 40 (54.8) 145 (52.5) 1.1(0.63–1.9) 0.8
CC 4 (5.5) 21 (7.6) 0.7(0.2–2.27) 0.7
TC 0 (0) 0 (0) 0.99(0.57–1.74) –
Complex FS and control
IL-10 GCC 21 (32.8) 99 (35.4) 0.89(0.48–1.65) 0.8
ACC 24 (37.5) 100 (35.7) 1.08(0.59–1.96) 0.9
ATA 19 (29.7) 81 (28.9) 1.04(0.55–1.95) 1
TGF-b CG 38 (48.7) 110 (39.9) 1.43(0.84–2.45) 0.2
TG 34 (43.6) 145 (52.5) 0.7(0.41–1.19) 0.2
CC 4 (5.1) 21 (7.6) 0.66(0.18–2.11) 0.6
TC 2 (2.6) 0 (0) – 0.048
Bold value indicates the p value is below 0.05 and the genotype and haplotype difference between cases and controls are signiﬁcant.
A. Shahrokhi et al. / Seizure 29 (2015) 148–152 1513.2. haplotype polymorphisms
The frequency of haplotypes of IL-10 (-1082, -819, -592) and
TGFB (codons 10 and 25) in patients with FS and controls are
shown in Table 3. Haplotype analysis revealed signiﬁcant
difference in the frequency of TGFB/TC haplotype in comparison
between complex FS patients and controls (p = 0.048).
4. Discussion
Production of cytokines seems to be affected by SNPs within the
coding regions of the genes encoding the cytokines [8]. Cytokines
are highly inducible, secreted proteins interposing intercellular
communication in the nervous and immune system [29]. Fever
regulates by central thermoregulatory mechanisms localized in the
preoptic area of the hypothalamus [29]. Its induction is mediated
by the release of pyrogenic cytokines such as TNF, IL-1, IL-6, and
interferons into the bloodstream in response to exogenous
pyrogens [30]. IL-10 is a cytokine with multiple roles in
inﬂammatory system, produced by monocytes, macrophages, B
cells, T cells and microglias ([13,31]. It inhibits the production of
proinﬂammatory cytokines including TNFA, IL-1, IL-6, and IL-8
[32]. Kurreeman et al. have been reported that the IL-10 -592C
allele and -1082A/-819C/-592C (ACC) haplotype, are associated
with increased production of IL-10 [33].
In the present study, we found no an association between the
IL-10 gene and resistance to FS. Also we found no differences in
allelic/genotype frequency of IL-10 between simple and complex
FS samples. Three studies have provided conﬂicting results as to
the relationship between FS and IL-10. Straussberg et al. have
shown increased lipopolysaccharide-induced IL-10 production by
peripheral blood mononuclear cells from children with a history of
FS [14]. Ishizaki et al. demonstrated an association between the
IL-10 gene and resistance to FS [34]. In contrast, Virta et al. have
reported that no difference in plasma IL-10 level was foundbetween children with and without FS [35]. Therefore, involve-
ment of IL-10 in the pathogenesis of FS is still unclear.
TGFB family proteins are pleiotropic cytokines that play a pivotal
role in intercellular communication, cell growth, embryogenesis and
immune response [36]. TGFB is considered an injury-related
cytokine that is up regulated in different forms of brain injury
[37]. Blockade of TGFB signaling prevents the transcriptome proﬁles
activated in astrocytes during epileptogenesis, brain inﬂammation
and reduces the occurrence of spontaneous seizures [36].
In the present study, the frequency of the CC genotype at
the TGFB/codon 10 (rs1982037) was signiﬁcantly underrepre-
sented in patients compared to controls. For TGFB at codon 25
(rs1800471), there were no signiﬁcant difference in allele
frequencies between our patients and controls. A signiﬁcant
negative association was observed at the TGFB codon 10/CT in the
patient group and simple FS samples. Also, the TGFB/TC haplotype
was the most frequent haplotype in patients with FS and was
signiﬁcantly over represented in patients compared to controls.
Genetic factors play a pivotal role in the etiology of epilepsies
[38]. Genetic studies of multifactorial disease, such as FS
and epilepsy, are difﬁcult to approach because of the uncertainty
of a polygenic trait [14]. Also, geographic and ethnic variations and
molecular heterogeneity may account for different results. Further
studies on ethnicities from different parts of the world and larger
sample size, will provide additional understanding of the possible
role of cytokine gene polymorphisms in the susceptibility to FS and
progression to epilepsy.
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